LEUKEMIA, MYELOMONOCYTIC, CHRONIC
Clinical trials for LEUKEMIA, MYELOMONOCYTIC, CHRONIC explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, MYELOMONOCYTIC, CHRONIC trials appear
Sign up with your email to follow new studies for LEUKEMIA, MYELOMONOCYTIC, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental pill tested against seven rare blood diseases
Disease control CompletedThis study tested whether the drug dasatinib could help control several rare blood disorders including leukemia, myelofibrosis, and mastocytosis. Participants took dasatinib pills daily for as long as it helped control their disease. Researchers monitored blood counts and bone ma…
Matched conditions: LEUKEMIA, MYELOMONOCYTIC, CHRONIC
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New combo drug trial aims to tame aggressive blood cancers
Disease control CompletedThis large, completed study tested if adding a new drug called pevonedistat to the standard treatment (azacitidine) could better control certain aggressive blood cancers. It involved 454 adults with high-risk myelodysplastic syndromes, chronic myelomonocytic leukemia, or low-blas…
Matched conditions: LEUKEMIA, MYELOMONOCYTIC, CHRONIC
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC